The Conference on Retroviruses and Opportunistic Infections (CROI) brings together basic scientists and clinical investigators to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and associated diseases.
Posters
| Efficacy & safety of ravidasvir + sofosbuvir in hepatitis C: STORM-C-1 final results Tan SS, Thanprasertsuk S, Thongsawat S, Salvadori N, Menétrey C, and the STORM-C-1 Research Team |
| Pharmacokinetics of abacavir in African children < 14 kg dosed per WHO weight bands Chupradit S*, Wamalwa DC, Maleche-Obimbo E, Kekitiinwa AR, Mwanga-Amumpaire J, Bukusi EA, Nyandiko WM, Mbuthia JK, Swanson A and DNDi Clinical Team, Cressey TR, Punyawudho B, Musiime V for the LIVING Study Team |
| LIVING: 48-week data on LPV/r pellets in 990 children in resource-limited settings Wamalwa DC, Musiime V, Kekitiinwa AR, Mwanga-Amumpaire J, Musoke RN, Mbuthia JK, Maleche-Obimbo E, Nyandiko WM, Bukusi EA, Weisser M, Ulenga N, Diallo M*, Goyal V, Swanson A for LIVING study team |
* Presenting author
